Mivtachim The Workers Social Insurance Fund’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.5M | Hold |
1,875,521
| – | – | 7.16% | 3 |
|
|
2025
Q4 | $58.5M | Buy |
1,875,521
+158,790
| +9% | +$3.91M | 8.11% | 3 |
|
|
2025
Q3 | $34.7M | Hold |
1,716,731
| – | – | 5.06% | 7 |
|
|
2025
Q2 | $28.8M | Hold |
1,716,731
| – | – | 4.43% | 9 |
|
|
2025
Q1 | $26.4M | Hold |
1,716,731
| – | – | 4.36% | 8 |
|
|
2024
Q4 | $37.8M | Buy |
1,716,731
+331,000
| +24% | +$6.02M | 6.22% | 4 |
|
|
2024
Q3 | $25M | Sell |
1,385,731
-67,612
| -5% | -$1.18M | 3.42% | 10 |
|
|
2024
Q2 | $23.6M | Hold |
1,453,343
| – | – | 2.78% | 11 |
|
|
2024
Q1 | $20.5M | Hold |
1,453,343
| – | – | 1.98% | 13 |
|
|
2023
Q4 | $15.2M | Hold |
1,453,343
| – | – | 1.19% | 21 |
|
|
2023
Q3 | $14.8M | Hold |
1,453,343
| – | – | 1.27% | 22 |
|
|
2023
Q2 | $10.9M | Hold |
1,453,343
| – | – | 0.96% | 29 |
|
|
2023
Q1 | $12.9M | Hold |
1,453,343
| – | – | 0.8% | 23 |
|
|
2022
Q4 | $13.3M | Hold |
1,453,343
| – | – | 0.69% | 24 |
|
|
2022
Q3 | $11.7M | Sell |
1,453,343
-1,700,000
| -54% | -$15M | 0.87% | 29 |
|
|
2022
Q2 | $23.7M | Sell |
3,153,343
-1,100,000
| -26% | -$9.58M | 1.06% | 22 |
|
|
2022
Q1 | $39.9M | Hold |
4,253,343
| – | – | 1.44% | 16 |
|
|
2021
Q4 | $34.1M | Buy |
4,253,343
+650,000
| +18% | +$5.87M | 1.07% | 21 |
|
|
2021
Q3 | $35.1M | Hold |
3,603,343
| – | – | 1.18% | 21 |
|
|
2021
Q2 | $35.7M | Buy |
3,603,343
+270,000
| +8% | +$2.86M | 1.21% | 20 |
|
|
2021
Q1 | $38.5M | Hold |
3,333,343
| – | – | 1.42% | 18 |
|
|
2020
Q4 | $32.2M | Hold |
3,333,343
| – | – | 1.28% | 18 |
|
|
2020
Q3 | $30M | Sell |
3,333,343
-12,314
| -0.4% | -$130K | 1.25% | 19 |
|
|
2020
Q2 | $41.3M | Sell |
3,345,657
-200,000
| -6% | -$2.26M | 1.58% | 12 |
|
|
2020
Q1 | $31.8M | Sell |
3,545,657
-250,000
| -7% | -$2.56M | 1.31% | 12 |
|
|
2019
Q4 | $37.2M | Sell |
3,795,657
-1,522,561
| -29% | -$13.6M | 1.5% | 12 |
|
|
2019
Q3 | $36.6M | Buy |
5,318,218
+2,080,592
| +64% | +$15.9M | 1.47% | 12 |
|
|
2019
Q2 | $29.9M | Buy |
3,237,626
+1,218,700
| +60% | +$14.7M | 1.46% | 12 |
|
|
2019
Q1 | $31.7M | Buy |
2,018,926
+320,000
| +19% | +$5.64M | 1.8% | 9 |
|
|
2018
Q4 | $26.2M | Buy |
1,698,926
+570,000
| +50% | +$11.7M | 1.7% | 9 |
|
|
2018
Q3 | $24.3M | Buy |
1,128,926
+240,000
| +27% | +$5.57M | 1.42% | 9 |
|
|
2018
Q2 | $21.6M | Buy |
888,926
+188,926
| +27% | +$3.85M | 1.44% | 6 |
|
|
2018
Q1 | $12M | Sell |
700,000
-280,000
| -29% | -$5.47M | 0.85% | 11 |
|
|
2017
Q4 | $18.6M | Buy |
+980,000
| New | +$14.7M | 1.14% | 8 |
|
|
2017
Q3 | – | Sell |
-195,289
| Closed | -$6.49M | – | 13 |
|
|
2017
Q2 | $6.49M | Hold |
195,289
| – | – | 0.43% | 10 |
|
|
2017
Q1 | $6.27M | Sell |
195,289
-31,500
| -14% | -$1.07M | 0.45% | 7 |
|
|
2016
Q4 | $8.22M | Hold |
226,789
| – | – | 0.66% | 10 |
|
|
2016
Q3 | $10.4M | Hold |
226,789
| – | – | 0.87% | 11 |
|
|
2016
Q2 | $11.4M | Buy |
226,789
+81,689
| +56% | +$4.35M | 0.94% | 10 |
|
|
2016
Q1 | $7.76M | Buy |
145,100
+55,000
| +61% | +$3.23M | 0.57% | 15 |
|
|
2015
Q4 | $5.91M | Buy |
+90,100
| New | +$5.57M | 0.45% | 16 |
|
|
2015
Q3 | – | Sell |
-40,000
| Closed | -$2.36M | – | 26 |
|
|
2015
Q2 | $2.36M | Buy |
+40,000
| New | +$2.47M | 0.22% | 20 |
|
|
2014
Q1 | – | Sell |
-2,987
| Closed | -$120K | – | 20 |
|
|
2013
Q4 | $120K | Buy |
+2,987
| New | +$118K | 0.01% | 17 |
|
Other funds holding TEVA
HIIFS
PF
MMH
CI
MIFH
LIM
Mivtachim The Workers Social Insurance Fund's TEVA Position: Q1 2026 in Review
Mivtachim The Workers Social Insurance Fund held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 1,875,521 shares worth $56.5M. The position accounts for 7.16% of the portfolio, ranked #3.
Mivtachim The Workers Social Insurance Fund first reported a position in TEVA in Q4 2013 and has held it in 43 quarters since. The position peaked at $58.5M in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.
- Mivtachim The Workers Social Insurance Fund held 1,875,521 shares of Teva Pharmaceuticals worth $56.5M as of Q1 2026.
- Mivtachim The Workers Social Insurance Fund left its Teva Pharmaceuticals share count unchanged in Q1 2026.
- Teva Pharmaceuticals made up 7.16% of Mivtachim The Workers Social Insurance Fund's portfolio in Q1 2026, its #3 holding.
- Mivtachim The Workers Social Insurance Fund first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 43 quarters since.
- Mivtachim The Workers Social Insurance Fund's Teva Pharmaceuticals position peaked at $58.5M in Q4 2025.
- 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.
Based on Mivtachim The Workers Social Insurance Fund's 13F filing for Q1 2026, filed 13 May 2026.